Silmitasertib (Standard)
Silmitasertib (Standard) is the analytical standard of Silmitasertib. This product is intended for research and analytical applications. Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'.
Product Specifications
CAS Number
1009820-21-6
UNSPSC
12352100
Target
Autophagy; Casein Kinase; Reference Standards
Related Pathways
Autophagy; Cell Cycle/DNA Damage; Others; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C(C1=CC=C2C3=C(C(NC4=CC=CC(Cl)=C4)=NC2=C1)C=CN=C3)O
Molecular Formula
C19H12ClN3O2
Molecular Weight
349.77
References & Citations
[1]Siddiqui-Jain A, et al. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.
 Cancer Res. 2010 Dec 15;70 (24) :10288-98.|[2]Buontempo F, et al. Synergistic cytotoxic effects of PS-341 and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB. Oncotarget. 2016 Jan 12;7 (2) :1323-40.|[3]Chon HJ, et al. The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies. Front Pharmacol. 2015 Mar 31;6:70.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
302525-AP 200 µL
LEPRE1 (Prolyl 3-Hydroxylase 1, Growth Suppressor 1, Leucine- and Proline-enriched Proteoglycan 1, Leprecan-1, LEPRE1, GROS1, P3H1) (AP) discontinued
Sign In for Pricing
View Details